Patents by Inventor Thomas Dassinger

Thomas Dassinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10626391
    Abstract: The invention provides granules comprising A) at least one enzyme selected from at least one of the groups selected from transferases of EC 2, hydrolases of EC 3, lyases of EC 4 and isomerases of EC 5, B) at least one polymer selected from C1-C10-alkyl acrylate polymer, C1-C10-alkyl methacrylate polymer and C1-C10-alkyl acrylate-C1-C10-alkyl methacrylate copolymer, preferably C1-C10-alkyl acrylate-C1-C10-alkyl methacrylate copolymer and C) at least one inorganic carrier material.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: April 21, 2020
    Assignee: Evonik Operations GmbH
    Inventors: Frank Hellmers, Thomas Hueller, Thomas Dassinger, Oliver Thum
  • Patent number: 9844511
    Abstract: The invention relates to a coating composition suitable for the coating of a pharmaceutical or nutraceutical dosage form, comprising a core comprising one or more pharmaceutical or nutraceutical active ingredients, wherein the coating composition is comprising at least 20% by weight of an enteric core/shell polymer composition derived from an emulsion polymerization process, wherein either the core of the core/shell polymer composition is formed by a water-insoluble, not cross-linked polymer or copolymer and the shell of the core/shell polymer composition is formed by an anionic polymer or copolymer or vice versa.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: December 19, 2017
    Assignee: Evonik Roehm GmbH
    Inventors: Kathrin Nollenberger, Jan Hendrik Schattka, Rene Leubert, Florian Hermes, Manfred Assmus, Christian Meier, Thomas Dassinger, Thomas Riermeier
  • Publication number: 20170002342
    Abstract: The invention provides granules comprising A) at least one enzyme selected from at least one of the groups selected from transferases of EC 2, hydrolases of EC 3, lyases of EC 4 and isomerases of EC 5, B) at least one polymer selected from C1-C10-alkyl acrylate polymer, C1-C10-alkyl methacrylate polymer and C1-C10-alkyl acrylate-C1-C10-alkyl methacrylate copolymer, preferably C1-C10-alkyl acrylate-C1-C10-alkyl methacrylate copolymer and C) at least one inorganic carrier material.
    Type: Application
    Filed: March 3, 2015
    Publication date: January 5, 2017
    Applicant: EVONIK DEGUSSA GmbH
    Inventors: Frank Hellmers, Thomas Hueller, Thomas Dassinger, Oliver Thum
  • Publication number: 20140086997
    Abstract: The invention relates to a coating composition suitable for the coating of a pharmaceutical or nutraceutical dosage form, comprising a core comprising one or more pharmaceutical or nutraceutical active ingredients, wherein the coating composition is comprising at least 20% by weight of an enteric core/shell polymer composition derived from an emulsion polymerisation process, wherein either the core of the core/shell polymer composition is formed by a water-insoluble, not cross-linked polymer or copolymer and the shell of the core/shell polymer composition is formed by an anionic polymer or copolymer or vice versa.
    Type: Application
    Filed: June 17, 2011
    Publication date: March 27, 2014
    Applicant: Evonik Roehm GmbH
    Inventors: Kathrin Nollenberger, Jan Hendrik Schattka, Rene Leubert, Florian Hermes, Manfred Assmus, Christian Meier, Thomas Dassinger, Thomas Riermeier